Weekly Recap | Aehr Test +9.77%, consensus target above spot
I'm LongbridgeAI, I can summarize articles.Aehr Test rose 9.77% this week to close at $94.69. The S&P 500 fell 0.8% over the same stretch, so the stock outperformed the benchmark by about 10.57 percentage points. The move was far from smooth. Tuesday (8 Sep) opened low and closed at $90.79. Wednesday (9 Sep) spiked to $101.62 before settling at $95.56. Thursday (10 Sep) pulled back to $93.81. Friday (11 Sep) hit a high of $102.79, then faded to close at $94.69. Weekly amplitude came to 14.
The Week
Aehr Test rose 9.77% this week to close at $94.69. The S&P 500 fell 0.8% over the same stretch, so the stock outperformed the benchmark by about 10.57 percentage points. The move was far from smooth. Tuesday (8 Sep) opened low and closed at $90.79. Wednesday (9 Sep) spiked to $101.62 before settling at $95.56. Thursday (10 Sep) pulled back to $93.81. Friday (11 Sep) hit a high of $102.79, then faded to close at $94.69. Weekly amplitude came to 14.88%, so the tape read as a choppy advance that gave back part of the gains near the highs.
Key Events
The most substantive item was the 10 Sep midday report that Aehr Test surged 8.64%, with AI-related orders pushing backlog contracts above $100m and execution drawing capital against a weak tape. The same day, the company announced its annual shareholder meeting. On 8 Sep, two industry pieces framed the backdrop: one covered the 2026 migration from AI hardware into safe-haven assets, the other flagged Lam Research’s $3bn R&D push as the AI hardware race heats up. A 12 Sep report revisited why Aehr Test is drawing fresh attention. On filings, there was one material item this week: an ARS disclosure on 11 Sep, with limited market impact.
Analyst Ratings
Six brokers cover the name, and all six rate it buy. There are no hold, underweight or sell ratings. The consensus rating is strong buy, and the consensus target is $128, about 35.18% above the $94.69 close. The target range is wide, from $110 to $175: even the low end sits about 16.2% above spot, while the high end implies roughly 84.8% upside. Within the semiconductor materials and equipment group, Aehr Test’s rating rank is 21st out of 31 names, leaving it in the lower-middle part of the peer set.
The Week Ahead
On Tuesday 15 Sep, the New York Fed manufacturing index lands with a prior reading of 20.6 and a 14.75 consensus. Wednesday 16 Sep is busier: retail sales ex-autos show a prior of -0.3 against a 0.6 forecast; headline retail sales prior is -0.6 with a 0.9 forecast; import prices prior is 6; the NAHB housing market index prior is 35 versus a 34 forecast; and EIA weekly crude and Cushing crude stock data also print. Beyond macro, the annual shareholder meeting disclosed this week could bring company-level updates, though no date details are available here.
In Short
This week’s advance came with heavier trading: average daily volume was 3.64m shares, about 51.18% above the median, so participation picked up clearly. The broker view is uniformly constructive, with the consensus target roughly 35% above the current price. The latest session’s flow data, however, shows a split: net buying in large-lot trades alongside net selling in medium and small-lot trades. On valuation, the stock trades at a negative P/E and around 14.07x book; the P/E ratio is not a useful gauge for a loss-making company. The tension to track is whether the price can hold this week’s highs, and whether macro prints or the shareholder meeting add a fresh directional impulse.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
